201 related articles for article (PubMed ID: 10479725)
1. Needle-in-a-haystack detection and identification of base substitution mutations in human tissues.
Wilson VL; Wei Q; Wade KR; Chisa M; Bailey D; Kanstrup CM; Yin X; Jackson CM; Thompson B; Lee WR
Mutat Res; 1999 Aug; 406(2-4):79-100. PubMed ID: 10479725
[TBL] [Abstract][Full Text] [Related]
2. An endonuclease/ligase based mutation scanning method especially suited for analysis of neoplastic tissue.
Huang J; Kirk B; Favis R; Soussi T; Paty P; Cao W; Barany F
Oncogene; 2002 Mar; 21(12):1909-21. PubMed ID: 11896624
[TBL] [Abstract][Full Text] [Related]
3. Frequent detection of ras and p53 mutations in brush cytology samples from lung cancer patients by a restriction fragment length polymorphism-based "enriched PCR" technique.
Behn M; Qun S; Pankow W; Havemann K; Schuermann M
Clin Cancer Res; 1998 Feb; 4(2):361-71. PubMed ID: 9516924
[TBL] [Abstract][Full Text] [Related]
4. PCR bias toward the wild-type k-ras and p53 sequences: implications for PCR detection of mutations and cancer diagnosis.
Barnard R; Futo V; Pecheniuk N; Slattery M; Walsh T
Biotechniques; 1998 Oct; 25(4):684-91. PubMed ID: 9793653
[TBL] [Abstract][Full Text] [Related]
5. Detection of K-ras point mutation by enriched PCR-colorimetric plate assay.
Santiago FS; Todd AV; Hawkins NJ; Ward RL
Mol Cell Probes; 1997 Feb; 11(1):33-8. PubMed ID: 9076712
[TBL] [Abstract][Full Text] [Related]
6. Detection of rare mutant alleles by restriction endonuclease-mediated selective-PCR: assay design and optimization.
Fuery CJ; Impey HL; Roberts NJ; Applegate TL; Ward RL; Hawkins NJ; Sheehan CA; O'Grady R; Todd AV
Clin Chem; 2000 May; 46(5):620-4. PubMed ID: 10794742
[TBL] [Abstract][Full Text] [Related]
7. Detection of point mutations with a modified ligase chain reaction (Gap-LCR).
Abravaya K; Carrino JJ; Muldoon S; Lee HH
Nucleic Acids Res; 1995 Feb; 23(4):675-82. PubMed ID: 7534908
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic base substitution mutations in circulating leukocytes of normal individuals.
Wilson VL; Yin X; Thompson B; Wade KR; Watkins JP; Wei Q; Lee WR
Cancer Res; 2000 Apr; 60(7):1830-4. PubMed ID: 10766167
[TBL] [Abstract][Full Text] [Related]
9. Genotypic mutation analysis by RFLP/PCR.
Pourzand C; Cerutti P
Mutat Res; 1993 Jul; 288(1):113-21. PubMed ID: 7686255
[TBL] [Abstract][Full Text] [Related]
10. Selective 'stencil'-aided pre-PCR cleavage of wild-type sequences as a novel approach to detection of mutant K-RAS.
Lichtenstein AV; Serdjuk OI; Sukhova TI; Melkonyan HS; Umansky SR
Nucleic Acids Res; 2001 Sep; 29(17):E90-0. PubMed ID: 11522846
[TBL] [Abstract][Full Text] [Related]
11. Restriction endonuclease-mediated selective polymerase chain reaction: a novel assay for the detection of K-ras mutations in clinical samples.
Ward R; Hawkins N; O'Grady R; Sheehan C; O'Connor T; Impey H; Roberts N; Fuery C; Todd A
Am J Pathol; 1998 Aug; 153(2):373-9. PubMed ID: 9708798
[TBL] [Abstract][Full Text] [Related]
12. Detection of K-ras mutations in stools of patients with colorectal cancer by mutant-enriched PCR.
Nollau P; Moser C; Weinland G; Wagener C
Int J Cancer; 1996 May; 66(3):332-6. PubMed ID: 8621253
[TBL] [Abstract][Full Text] [Related]
13. Polymerase chain reaction/sequencing analysis of ras mutations in paraffin-embedded tissues as compared with 3T3 transfection and polymerase chain reaction/sequencing of frozen tumor deoxyribonucleic acids.
Goodrow TL; Prahalada SR; Storer RD; Manam SV; Leander KR; Kraynak AR; van Zwieten MJ; Nichols WW; Bradley MO
Lab Invest; 1992 Apr; 66(4):504-11. PubMed ID: 1583889
[TBL] [Abstract][Full Text] [Related]
14. Detection of rare K-ras codon 12 mutations using allele-specific competitive blocker PCR.
McKinzie PB; Parsons BL
Mutat Res; 2002 May; 517(1-2):209-20. PubMed ID: 12034322
[TBL] [Abstract][Full Text] [Related]
15. P53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis.
Chang KW; Sarraj S; Lin SC; Tsai PI; Solt D
Carcinogenesis; 2000 Jul; 21(7):1441-51. PubMed ID: 10874024
[TBL] [Abstract][Full Text] [Related]
16. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma.
Wilentz RE; Chung CH; Sturm PD; Musler A; Sohn TA; Offerhaus GJ; Yeo CJ; Hruban RH; Slebos RJ
Cancer; 1998 Jan; 82(1):96-103. PubMed ID: 9428484
[TBL] [Abstract][Full Text] [Related]
17. Use of PCR-PIRA for screening of a point mutation at codon 12 in K-ras oncogene obtained from paraffin embedded tissue sections.
Chewawiwat N; Lulitanond V; Nimmanahaeminda K; Thamprasert K; Nicomrat D; Ponglikitmongkol M
Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():329-32. PubMed ID: 8629136
[TBL] [Abstract][Full Text] [Related]
18. Ligation of a primer at a mutation: a method to detect low level mutations in DNA.
Kaur M; Zhang Y; Liu WH; Tetradis S; Price BD; Makrigiorgos GM
Mutagenesis; 2002 Sep; 17(5):365-74. PubMed ID: 12202623
[TBL] [Abstract][Full Text] [Related]
19. Multiplex polymerase chain reaction amplification and direct sequencing of homologous sequences: point mutation analysis of the ras genes.
Manam S; Nichols WW
Anal Biochem; 1991 Nov; 199(1):106-11. PubMed ID: 1807152
[TBL] [Abstract][Full Text] [Related]
20. Allele loss and point mutation in codons 12 and 61 of the c-Ha-ras oncogene in carcinogen-transformed human breast epithelial cells.
Zhang PL; Calaf G; Russo J
Mol Carcinog; 1994 Jan; 9(1):46-56. PubMed ID: 8297485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
